Home › Funds › Paradiem, LLC › DGX

Paradiem, LLC position in DGX

QUEST DIAGNOSTICS INC · Health Care

Paradiem, LLC reported holding 45,189 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$10.5M, representing 2.30% of its reported portfolio and ranking #11 among its reported holdings. Paradiem, LLC has disclosed DGX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)45.19K sh
Reported value held$10.53M
Portfolio Weight2.30%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Paradiem, LLC's DGX position evolved

Paradiem, LLC first disclosed a stake in DGX in Q4 2025 at 78,670 shares (US$13.7M). The position peaked in Q1 2026 at 71,480 shares, worth US$14.0M. Across 4 filings, Paradiem, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 45,189 shares valued at US$10.5M — a reduction of -14,276 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 78.67K $13.65M New
Q1 2026 71.48K $14.01M Reduce
Q2 2026 59.47K $12.60M Reduce
Q3 2026 45.19K $10.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 26 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.08B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$449.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has Paradiem, LLC held DGX?

Paradiem, LLC has disclosed DGX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Paradiem, LLC's current position in DGX?

As of Q3 2026, Paradiem, LLC holds 45.19K shares of DGX (QUEST DIAGNOSTICS INC), valued at $10.53M, representing 2.30% of its reported portfolio and ranking #11.

Has Paradiem, LLC been buying or selling DGX?

In the latest 13F filing (Q3 2026), Paradiem, LLC reduced its position in DGX. The position peaked in Q1 2026 at 71.48K shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.